Understanding Cancer

With so many of us heavily invested here at IMU hoping for a breakthrough in treating cancer, it might be time to have a better understanding of cancer.

  Warning!  This will require a little time to understand. I have linked a podcast from I’m Dr Peter Attia who is a longevity specialist and author .  He is interviewing Keith Flaherty who sold Loxo Oncology to Ely Lilly for $8bn several years ago.  That sale was a headline event.

https://www.pharmaceutical-technology.com/news/lilly-closes-loxo-oncology-acquisition/


In the opening few minutes they discuss pancreatic cancer, which is the fifth most prevalent cancer.  Which is also one of if not the hardest cancer to treat.. As you are all well aware IMU has done a research deal with  RenovoRx with a view to using their TAMP technology to deliver CR33 to the pancreas.

This conversation will really add a lot of context to our understanding of what IMU is trying to acheive.  And the enormity of the market IMU is targeting.

And from a general health perspective, there is a lot to be gained.  Including a fascinating fact that I was not aware of regarding Testosterone levels and cancer in men!  

Hope you take the time to listen and learn a lot about your investment here. From an expert. A very successful expert.

https://podcasts.apple.com/au/podcast/the-peter-attia-drive/id1400828889?i=1000625105921